AlloVir is headquartered in Lexington, MA.
Our shares began trading on July 30, 2020, at a price of $17.00 per share.
Our fiscal year ends on December 31st.
AlloVir is traded on the Nasdaq Global Market under the ticker symbol ALVR.
AlloVir does not pay dividends.
The transfer agent and registrar for AlloVir’s common stock is Computershare.
Investor Center website
www.computershare.com/investor
Telephone inquiries
1-800-736-3001 (US, Canada, Puerto Rico)
1-781-575-3100 (non-US)
Written requests
Computershare
P.O. Box 505000
Louisville, KY 40233-5000
By overnight delivery
Computershare
462 South 4th Street, Suite 1600
Louisville KY 40202
Email
web.queries@computershare.com
Shareholder Online Inquiries
https://www-us.computershare.com/investor/Contact
Please contact the transfer agent above.
AlloVir’s independent auditors are Deloitte and Touche LLP, located in Boston, MA.
Deloitte and Touche LLP
200 Berkeley Street
10th Floor
Boston, MA 02116
AlloVir’s legal counsel is Goodwin Procter, located in Boston, MA.
Goodwin Proctor
100 Northern Ave
Boston, MA 02210
As of December 31, 2022, AlloVir has approximately 100 employees.
More information on AlloVir can be found at www.allovir.com
Investor and media-related information is at ir.allovir.com.
AlloVir’s SEC filings are available here. Presentations, annual reports, and other investor-related materials are available ir.allovir.com.
More information on AlloVir’s leadership, Board of Directors, and Advisors can be found here.
Sign up for email alerts here.
For investor inquires, please contact ir@allovir.com.
